Clinical Trial: An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Application on the Skin of Healthy Chinese Subjects, Using a Randomized, Double-blind, Parallel-controlled Design With Vehicle Ointment as Comparator.

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673458) titled 'An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Application on the Skin of Healthy Chinese Subjects, Using a Randomized, Double-blind, Parallel-controlled Design With Vehicle Ointment as Comparator.' on June 22.

Brief Summary: The goal of this clinical trial is to evaluate the safety, local tolerability, and pharmacokinetic (PK) profile of YR001 Topical Ointment in healthy Chinese participants. This is a first-in-China, Phase I study designed to assess the drug's systemic absorption and disposition following single and multiple topical applications.

The main ques...